Ekgaluck Wanothayaroj
Ekgaluck Wanothayaroj has a total of 16 co-authors. Here are the top co-authors by number of shared publications:
Sirinate Krittiyawong
Diabetes and Thyroid Center, Theptarin Hospital, Bangkok, Thailand
2 shared publications- Soontaree Nakasatien
THEPTARIN Diabetes, Thyroid and Endocrine Center, Vimut-Theptarin Hospital , Bangkok 10110
2 shared publications Sriurai Porramatikul
Diabetes and Thyroid Center, Theptarin Hospital, Bangkok, Thailand
2 shared publications- Thep Himathongkam
THEPTARIN Diabetes, Thyroid and Endocrine Center, Vimut-Theptarin Hospital , Bangkok 10110
2 shared publications - Yotsapon Thewjitcharoen
Theptarin Diabetes, Thyroid and Endocrine Center, Vimut-Theptarin Hospital, Bangkok, Thailand
2 shared publications Jirapat Jeamjiraprasert
Division of Laboratory, Theptarin Hospital, Bangkok, Thailand
1 shared publication
Latest Publications
- Open Access
- 7 February 2024
- Published by Taylor & Francis in Journal of Pharmaceutical Policy and Practice
- Vol. 17 (1) , 2306866
Expert consensus guidelines for community pharmacists in the management of diabetic peripheral neuropathy with a combination of neurotropic B vitamins
This consensus guidance is for community pharmacists in diabetic peripheral neuropathy (DPN) management with a combination of neurotropic B vitamins. A multidisciplinary team including endocrinology, neurology, and pharmacy from Thailand discussed and aligned the practical scheme of DPN management in the community pharmacy setting, using the literature review and having face-to-face meeting. Five major statements have been endorsed as consensus recommendations for DPN care with strong acknowledgment. The aims of DPN management included reducing symptoms and the risk of complications, minimising adverse reactions from treatment regimens, and improving patients’ knowledge and adherence to the treatment strategies. An initial screening process using a 7 items interview of Douleur Neuropathique 4 (DN4) questionnaire should be implemented to identify patients at risk of developing DPN. Subsequently, pharmacologic, and non-pharmacologic treatment should be employed based on patient-centered care. An interesting approach is combination of neurotropic B vitamins, which may be used as monotherapy or combination therapy to control DPN symptoms. The combined therapy potentially exhibits a synergistic effect and improves patient adherence. The consensus would be further considered in context of harmonisation of routine practice and country requirements.
- 7 February 2024
- Published by Taylor & Francis in Journal of Pharmaceutical Policy and Practice
- Vol. 17 (1) , 2306866
Open AccessExpert consensus guidelines for community pharmacists in the management of diabetic peripheral neuropathy with a combination of neurotropic B vitamins
This consensus guidance is for community pharmacists in diabetic peripheral neuropathy (DPN) management with a combination of neurotropic B vitamins. A multidisciplinary team including endocrinology, neurology, and pharmacy from Thailand discussed and aligned the practical scheme of DPN management in the community pharmacy setting, using the literature review and having face-to-face meeting. Five major statements have been endorsed as consensus recommendations for DPN care with strong acknowledgment. The aims of DPN management included reducing symptoms and the risk of complications, minimising adverse reactions from treatment regimens, and improving patients’ knowledge and adherence to the treatment strategies. An initial screening process using a 7 items interview of Douleur Neuropathique 4 (DN4) questionnaire should be implemented to identify patients at risk of developing DPN. Subsequently, pharmacologic, and non-pharmacologic treatment should be employed based on patient-centered care. An interesting approach is combination of neurotropic B vitamins, which may be used as monotherapy or combination therapy to control DPN symptoms. The combined therapy potentially exhibits a synergistic effect and improves patient adherence. The consensus would be further considered in context of harmonisation of routine practice and country requirements.
- Open Access
- 2 September 2020
- Published by Elsevier in Journal of Clinical & Translational Endocrinology
- Vol. 21, 100235
Impact of first-line treatment choice on long-term outcomes of hyperthyroid Graves’ disease patients with thyrotoxic periodic paralysis
- 2 September 2020
- Published by Elsevier in Journal of Clinical & Translational Endocrinology
- Vol. 21, 100235
Open AccessImpact of first-line treatment choice on long-term outcomes of hyperthyroid Graves’ disease patients with thyrotoxic periodic paralysis
- Open Access
- 6 May 2017
- Published by Elsevier in Journal of Clinical & Translational Endocrinology
- Vol. 8, 35-40
A study of serum IgG4 levels in the clinical metamorphosis of autoimmune thyroid disease
- 6 May 2017
- Published by Elsevier in Journal of Clinical & Translational Endocrinology
- Vol. 8, 35-40
Open AccessA study of serum IgG4 levels in the clinical metamorphosis of autoimmune thyroid disease